Kampanjeplan Oragenics, Inc.
Avansert tidsplan
Enkel graf
Om selskapet Oragenics, Inc.
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. flere detaljer| IPO date | 2004-02-25 |
|---|---|
| ISIN | US6840233026 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.oragenics.com |
| Цена ао | 0.2462 |
| Prisendring per dag: | -7.65% (0.234) |
|---|---|
| Prisendring per uke: | -16.88% (0.26) |
| Prisendring per måned: | -22.82% (0.28) |
| Prisendring over 3 måneder: | -52.35% (0.4535) |
| Prisendring over seks måneder: | -43.31% (0.3812) |
| Prisendring per år: | -84.99% (1.44) |
| Prisendring over 3 år: | -39.64% (0.358) |
| Prisendring over 5 år: | -58.95% (0.5264) |
| Prisendring siden begynnelsen av året: | -42.83% (0.378) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Charles L. Pope CPA | Executive Chairman | 1952 (73 år) | |
| Mr. Joseph Michael Redmond | President & Interim Principal Executive Officer | 1961 (64 år) | |
| Ms. Janet Huffman | CFO, Secretary & Treasurer | 1972 (53 år) | |
| Dr. James P. Kelly M.A., M.D. | Chief Medical Officer & Member of Scientific Advisor | ||
| Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D. | Chief Clinical Officer |
Adresse: United States, Tampa, 4902 Eisenhower Boulevard - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.oragenics.com
Nettsted: https://www.oragenics.com
